Cas 150903-48-3,(S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester

150903-48-3

Post Buying Request

Basic information

Product Name: (S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester
Synonyms: (S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester
CAS NO:150903-48-3
Molecular Formula:
Molecular Weight: 521.634
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester(150903-48-3)
EPA Substance Registry System: (S)-2-[2-Acetylsulfanylmethyl-3-(4-hydroxy-phenyl)-butyrylamino]-3-(4-hydroxy-phenyl)-propionic acid benzyl ester(150903-48-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 150903-48-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

150903-48-3 Suppliers

Recommended suppliers

150903-48-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 150903-48-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,9,0 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 150903-48:
(8*1)+(7*5)+(6*0)+(5*9)+(4*0)+(3*3)+(2*4)+(1*8)=113
113 % 10 = 3
So 150903-48-3 is a valid CAS Registry Number.

150903-48-3Upstream product

150903-48-3Downstream Products

150903-48-3Relevant academic research and scientific papers

New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: Rational design, bioavailability, and pharmacological responses in experimental hypertension

Fournie-Zaluski,Coric,Turcaud,Rousselet,Gonzalez,Barbe,Pham,Jullian,Michel,Roques

, p. 1070 - 1083 (2007/10/02)

In the treatment of cardiovascular diseases, it could be of therapeutic interest to associate the hypotensive effects resulting from the inhibition of angiotensin II formation, ensured by endothelial angiotensin-converting enzyme (ACE), with the diuretic

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 150903-48-3